• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/17

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

17 Cards in this Set

  • Front
  • Back

MOA of cell wall synthesis inhibitors + Examples

Inhabit some step in bacterial peptidoglycan synthesis. (Selective toxicity bc human cells have no cell wall)


Penicillins - penicillin G, amp, amox, clox


Cephalosporins - ceftazidime


Glycopeptides - van

Beta lactam antibiotics

Products of 2 fungi molds (penicillium and cephalosporium)

Semi synthetic antibiotics

Amox + amp + meth (against gram -)

MOA of cell membrane inhibitors & examples

Disorganize the membranes which rapidly kills the cells


Polymyxin


Polyene


Azoles eg Imidazole (inhabits ergosterol synthesis)

MOA of protein synthesis inhibitors & examples

Inhibit some step of protein synthesis


Tetracycline - tetra, doxy


Chloramphenicol


Macrolides - erythromycin


Aminoglycosides - strep, genta, kana

MOA of drugs ch act on Nucleic Acids & Examples

Blocks cell growth by affecting DNA/RNA synthesis or binding to it so theirs msgs cannot be read


Quinolones - ciprofloxacin, naldic acid


Sulfonamides + Trimethoprim - co trimoxazole, trimethoprim


Metronidazole

MOA of sulfonamides (competitive inhibitor/anti metabolite)

Sulfonamides are structural analogs of PABA and compete w it for the enzyme that combines PABA and pteridine (dihydropteroate synthetase) in the initial stage of folate synthesis

Mechanisms of Antimicrobial Resistance (list 3)

1. Produce enzymes to inactivate antibiotics eg beta-lactamase destroys penicillins + cephalosporins


2. Alter membrane to prevent antibiotic uptake eg changing permeability in tetra res


3. Modifies target to prevent interaction w antibiotic eg mutations to change receptor

Mechanisms of Antimicrobial Resistance (list 3)

4. Dev of metabolic pathways that by pass site of action of antibiotic eg sulfonamides + trimeth resistance


5. Increasing production of metabolites which overcomes “tying up” of bacterial enzymes wrt drugs that resemble substrates


6. Efflux pump - channels that actively export antibiotics out of the cell as soon as it enters

Control of Resistance (list 9)

Conservative + specific use


Enough amt + long enough to eliminate


Select according to known susceptibility


Narrow spectrum when etiology is known


Use combinations


Prophylaxis only if proven valuable + short T


Avoid envi contamination


Aseptic handling to prevent spread of resist


Don’t use therapeutically valuable antibiotics for non medical purposes

When is Antimicrobial Sensitivity/Susceptibility testing performed?

Organisms w variable sensitivity eg Shigella


Patients not responding to adequate therapy


Patients w depressed IS


Relapsing cases

When is Antimicrobial Sensitivity testing NOT performed?

If bacteria is a normal flora contaminant


If culture is mixed ie not pure


For organisms w predicable sensitivity (S pyogens + N meningitis sensitive to penicillin while Proteus spp resistant to tetracyclines)

Principle of Dilution Technique for sensitivity

1. Graded amts of antibiotic is added to agar or broth


2. Inoculated w test bacteria 🧫


3. Turbidity indicates growth


MIC (min inhibitory conc) - smallest amt of agent needed to inhibit growth of test bacteria


MBC (min bactericidal conc) - “ “ to kill “ “

Principle of Disk Diffusion in Sensitivity Testing

1. Impregnate disk of blotting paper with known vol + conc of agent


2. Place on plate of agar 🧫 uniformly inoculated w test organism


3. Agent diffuses from disk to medium and the growth of the test 🦠 is inhibited @ a distance related to its sensitivity


Resistant - smaller zones of inhibition

External Factors influencing Zone size in Disk Diffusion Test (list 5)

Inoculum density (McFarland’s Std) - too heavy -> size falsely reduced -> false resistance


Time of disk app (3-5m) - longer -> size falsely reduced -> false resistance


Temp - too 🥶 -> inhibits growth -> size falsely increased -> false sensitivity


Agar depth (4mm) - less -> size falsely increased -> false sensitivity


Disk potency - deteriorated potency -> size falsely reduced -> false resistance

Interpretation of Zone Size

Resistant - will NOT respond to r/x regardless of dose or site


Intermediate- likely to respond to larger doses than normal or conc @ infection site (consider other drugs)


Sensitive - will reposed to r/x @ normal doses

WHO recommends the Kirby-Bauer NCCLS Modified Disk Diffusion techniques for standardization... what does this entail?

1. Reliable Muller Hinton agar - prepare medium (ph 7.2-7.4), pour 25ml of MHA per plate on level surface, use control strain + stored @ 2-8oC for up to 2w


2. Discs of correct Antimicrobial content


3. Turbidity std = McFarland’s 0.5 - barium sulfate std against ch the turbidity of the test and control inocula can be compared